Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-19 4:0:59 am | Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder | GlobeNewsWire |
| 2024-03-13 12:32:20 pm | 11 Oversold NASDAQ Stocks To Buy Right Now | Insider Monkey |
| 2024-03-05 4:0:0 am | Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference | GlobeNewswire |
| 2024-02-27 4:0:0 am | Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference | GlobeNewswire |
| 2024-02-26 12:4:0 pm | 3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 | InvestorPlace |
| 2024-02-26 5:50:0 am | 3 Biotech Stocks to Buy and Hold for the Next 10 Years | Motley Fool |
| 2024-02-21 7:39:0 am | Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat | Zacks |
| 2024-02-21 6:23:32 am | Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript | Insider Monkey |
| 2024-02-20 7:39:40 pm | Q4 2023 Axsome Therapeutics Inc Earnings Call | Thomson Reuters StreetEvents |
Please consider a small donation if you think this website provides you with relevant information